Boston Scientific resumes enrolment in pulsed field ablation trial
Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...
FierceBiotech3d
Boston Scientific resumes Farapulse pulsed field ablation study in first-line afib
Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.
Daily6d
Johnson & Johnson MedTech bags USFDA nod for the Varipulse Pulsed Field Ablation Platform for atrial fibrillation
Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...
MassDevice6d
Boston Scientific resumes study of pulse field ablation as first-line AFib therapy
Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...
health.economictimes.indiatimes6d
US FDA approves Johnson & Johnson's device for heart condition
The device, Varipulse, is a pulsed field ablation system which uses small burns or freezes to cause some scarring in the ...
Boston Scientific resumes PFA trial in new patient group after pausing enrollment
Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to anti-arrhythmic drugs in patients with persistent AFib, a spokesperson said.
abc276d
Using Pulse Field Ablation to Treat Atrial Fibrillation – Penn State Health
More than six million Americans experience atrial fibrillation, or Afib, each year. Penn Stare Health Heart and Vascular is now offering a new, very focused and safe approach to treating Afib, ...